Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

In Brief Winter 2025

  • ALK Positive

    ALK Positive

    ALK Positive has gifted a generous grant to support Dana-Farber Cancer Institute’s Alice Shaw, MD, PhD’s, pioneering research on methylthioadenosine phosphorylase loss in ALK-positive lung cancer. This vital funding will drive innovative strategies to improve patient outcomes, empowering breakthroughs that enhance care for individuals affected by ALK-positive lung cancer worldwide.

    Continue Reading

  • The Terri Brodeur Breast Cancer Foundation

    The Terri Brodeur Breast Cancer Foundation

    The Terri Brodeur Breast Cancer Foundation awarded $125,000 to Genevra Kuziel, PhD, supporting her research on estrogen receptor-positive (ER+) breast cancer, the most common breast cancer subtype with a high recurrence rate. Kuziel’s work aims to develop innovative combination therapies, with the goal of transforming treatment options and improving outcomes for patients.

    Continue Reading

  • Craig and Bettina Burr

    Craig and Bettina Burr

    Craig and Bettina Burr gave $100,000 towards the Bettina and Craig Burr Breast Cancer Genetics and Prevention Research Fund at Dana-Farber Cancer Institute. This gift will support the research of Judy Garber, MD, MPH, the Susan F. Smith Chair at Dana-Farber, and Myles Brown, MD, the Emil Frei III, MD, Professor of Medicine at Harvard…

    Continue Reading

  • Cancer Prevention Initiative 

    Cancer Prevention Initiative 

    The Cancer Prevention Initiative (CPI) awarded $450,000 to Kornelia Polyak, MD, PhD, for her breast cancer research at Dana-Farber Cancer Institute, targeting early tumor progression. This grant highlights CPI’s vital support for and shared mission with Dana-Farber in advancing impactful strategies for early medical interception of inherited cancer to improve patient outcomes.

    Continue Reading

  • Children’s Cancer Research Fund 

    Children’s Cancer Research Fund 

    The Children’s Cancer Research Fund made two grants totaling $350,000 to support an early phase trial for relapsed pediatric liver cancer led by Allison O’Neill, MD, and liquid biopsy research in rhabdomyosarcoma led by Brian Crompton, MD. These pivotal resources help to develop more effective precision therapies for children facing aggressive cancers.

    Continue Reading

  • The Cure Alzheimer’s Fund   

    The Cure Alzheimer’s Fund   

    The Cure Alzheimer’s Fund awarded $201,250 to Peter Sicinski, MD, PhD, to advance his research on anticancer compounds that may reverse Alzheimer’s symptoms. His work focuses on preclinical validation, investigating their potential to restore memory and synaptic health, and uncovering molecular mechanisms—offering hope for transformative Alzheimer’s treatments.

    Continue Reading

  • John and Hallie Dovich Fund  

    John and Hallie Dovich Fund  

    Hallie and John Dovich generously gifted $100,000 to Dana-Farber Cancer Institute, establishing the John and Hallie Dovich Fund. Under the direction of Vincent Ho, MD, this fund will support stem cell transplantation research, to improve transplant outcomes for patients with for patients with myelofibrosis and other blood cancers, ultimately enhancing patient care and treatment strategies.

    Continue Reading

  • Charles H. Hood Foundation 

    Charles H. Hood Foundation 

    The Charles H. Hood Foundation awarded Emily Heikamp, MD, PhD, MSc, a generous $200,000 grant to study a combination treatment for acute myeloid leukemia targeting oncogenic fusion proteins and foster her career development as an independent investigator. This funding supports high-risk, high-reward pediatric studies, enabling groundbreaking discoveries, improved care, and ideally better outcomes for young…

    Continue Reading

  • International Cancer Advocacy Network 

    International Cancer Advocacy Network 

    The Exon 20 Group's International Research Consortium at the International Cancer Advocacy Network (ICAN) awarded $100,000 to Michael Eck, MD, PhD, to improve our understanding of common EGFR exon 20 insertion variants, which will be valuable for the development of potent and selective inhibitors for EGFR-mutant non-small cell lung cancer. This funding can accelerate the…

    Continue Reading

  • Lymphoma Research Foundation 

    Lymphoma Research Foundation 

    The Lymphoma Research Foundation awarded Dana-Farber Cancer Institute's Tianfang Ma, PhD, a generous $195,000 Postdoctoral Fellowship Grant, to bolster his research and growth as an independent investigator. Ma’s work focuses on the tumor immune microenvironment in diffuse large B-cell lymphoma and may help enhance immunotherapy effectiveness and identify predictive markers to improve patient outcomes.

    Continue Reading